Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment

Journal of Periodontal Research

Volumn 45, Issue 4, 2010, Pages 458-463

  Andersen, Elene ^a   Dessaix, I M ^a   Perneger, T ^b   Mombelli, A ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Calprotectin; Chronic periodontitis; Gingival crevice fluid; Myeloid related protein

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B;

ADULT; AGED; ALVEOLAR BONE LOSS; AREA UNDER THE CURVE; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FOLLOW UP; GINGIVA BLEEDING; GINGIVITIS; HUMAN; METABOLISM; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTIUM; RECEIVER OPERATING CHARACTERISTIC; TOOTH PLAQUE;

ADULT; AGED; ALVEOLAR BONE LOSS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTIUM; ROC CURVE;

EID: 77954838578     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01257.x     Document Type: Article

References (43)

1. Loos BG, Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000 2005, 39:53-72.
2. Armitage GC. Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontol 2000 2004, 34:109-119.
3. Que ML, Andersen E, Mombelli A. Myeloid-related protein (MRP)8/14 (calprotectin) and its subunits MRP8 and MRP14 in plaque-induced early gingival inflammation. J Clin Periodontol 2004, 31:978-984.
4. Miyasaki KT, Voganatsi A, Huynh T, Marcus M, Underwood S. Calprotectin and lactoferrin levels in the gingival crevicular fluid of children. J Periodontol 1998, 69:879-883.
5. Smith QT, Au GS, Freese PL, Osborn JB, Stoltenberg JL. Five parameters of gingival crevicular fluid from eight surfaces in periodontal health and disease. J Periodontal Res 1992, 27:466-475.
6. Ross KF, Herzberg MC. Calprotectin expression by gingival epithelial cells. Infect Immun 2001, 69:3248-3254.
7. Altwegg LA, Neidhart M, Hersberger M. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007, 28:941-948.
8. Suryono, Kido J, Hayashi N, Kataoka M, Nagata T. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J Periodontol 2005, 76:437-442.
9. Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. Oral Microbiol Immunol 2004, 19:182-187.
10. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336:763-765.
11. Lugering N, Stoll R, Kucharzik T. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 1995, 56:406-414.
12. Tibble J, Teahon K, Thjodleifsson B. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000, 47:506-513.
13. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet 2000, 356:1783-1784.
14. Burmeister G, Gallacchi G. A selective method for determining MRP8 and MRP14 homocomplexes and heterocomplexes by sandwich ELISA for the discrimination of active and non-active osteoarthritis from rheumatoid arthritis in sera and synovial fluids. Inflammopharmacol 1995, 3:221-230.
15. Odink K, Cerletti N, Bruggen J. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987, 330:80-82.
16. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003, 18:756-762.
17. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1996, 74:136-139.
18. Barthe C, Figarella C, Carrere J, Guy-Crotte O. Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim Biophys Acta 1991, 1096:175-177.
19. Hammer HB, Odegard S, Fagerhol MK. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 2007, 66:1093-1097.
20. Berntzen HB, Olmez U, Fagerhol MK, Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991, 20:74-82.
21. Frosch M, Strey A, Vogl T. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:628-637.
22. Benoit S, Toksoy A, Ahlmann M. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol 2006, 155:62-66.
23. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol 1980, 24:393-398.
24. Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984, 44:357-362.
25. Kojima T, Andersen E, Sanchez JC. Human gingival crevicular fluid contains MRP8 (S100A8) and MRP14 (S100A9), two calcium-binding proteins of the S100 family. J Dent Res 2000, 79:740-747.
26. Giannopoulou C, Andersen E, Brochut P, Plagnat D, Mombelli A. Enamel matrix derivative and systemic antibiotics as adjuncts to non-surgical periodontal treatment: biologic response. J Periodontol 2006, 77:707-713.
27. Kido J, Nakamura T, Kido R. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J Clin Periodontol 1999, 26:653-657.
28. Lundy FT, Chalk R, Lamey PJ, Shaw C, Linden GJ. Quantitative analysis of MRP-8 in gingival crevicular fluid in periodontal health and disease using microbore HPLC. J Clin Periodontol 2001, 28:1172-1177.
29. Kaner D, Bernimoulin JP, Kleber BM, Heizmann WR, Friedmann A. Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis. J Periodontal Res 2006, 41:132-139.
30. Nakamura T, Kido J, Kido R. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol 2000, 71:361-367.
31. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997, 2:123-137.
32. Gustafsson A, Asman B, Bergstrom K. Lower protein concentration in GCF from patients with periodontitis: an indicator of host-specific inflammatory reaction. J Clin Periodontol 1995, 22:225-228.
33. Murray MC, Mooney J, Kinane DF. The relationship between elastase and lactoferrin in healthy, gingivitis and periodontitis sites. Oral Dis 1995, 1:106-109.
34. Jin LJ, Soder PO, Asman B, Soder B, Puriene A, Bergstrom K. Variations in crevicular fluid elastase levels in periodontitis patients on long-term maintenance. Eur J Oral Sci 1995, 103:84-89.
35. Teles RP, Sakellari D, Teles FRF. Relationship among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. J Periodontol 2009, 80. online ahead of print
36. Nonnenmacher C, Helms K, Bacher M. Effect of age on gingival crevicular fluid concentrations of MIF and PGE2. J Dent Res 2009, 88:639-643.
37. Holmlund A, Hanstrom L, Lerner UH. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. J Clin Periodontol 2004, 31:475-482.
38. Jin LJ, Leung WK, Corbet EF, Soder B. Relationship of changes in interleukin-8 levels and granulocyte elastase activity in gingival crevicular fluid to subgingival periodontopathogens following non-surgical periodontal therapy in subjects with chronic periodontitis. J Clin Periodontol 2002, 29:604-614.
39. Grbic JT, Lamster IB, Fine JB. Changes in gingival crevicular fluid levels of immunoglobulin A following therapy: association with attachment loss. J Periodontol 1999, 70:1221-1227.
40. Figueredo CM, Areas A, Miranda LA, Fischer RG, Gustafsson A. The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J Clin Periodontol 2004, 31:615-619.
41. Marin Dessaix I, Andersen E, Mombelli A. GCF Elastase and Interleukin-8, and the treatment outcome of scaling and root planing. Perio 2006, 3:15-23.
42. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003, 31:167-180.
43. Mombelli A, Meier C. On the symmetry of periodontal disease. J Clin Periodontol 2001, 28:741-745.